Leanne M. Kelly is Chief Financial Officer of Vallon Pharmaceuticals, Inc.. Currently has a direct ownership of 6,250 shares of VLON, which is worth approximately $0. The most recent transaction as insider was on Jun 04, 2021, when has been sold 1,508 shares (Common Stock) at a price of $4.08 per share, resulting in proceeds of $6,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.25K
0% 3M change
0% 12M change
Total Value Held $0

Leanne M. Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2021
BUY
Open market or private purchase
$6,153 $4.08 p/Share
1,508 Added 19.44%
6,250 Common Stock
Jun 03 2021
BUY
Open market or private purchase
$4,394 $4.05 p/Share
1,085 Added 18.62%
4,742 Common Stock
Jun 02 2021
BUY
Open market or private purchase
$14,628 $4.0 p/Share
3,657 Added 50.0%
3,657 Common Stock
LMK

Leanne M. Kelly

Chief Financial Officer
Philadelphia, PA

Track Institutional and Insider Activities on VLON

Follow Vallon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VLON shares.

Notify only if

Insider Trading

Get notified when an Vallon Pharmaceuticals, Inc. insider buys or sells VLON shares.

Notify only if

News

Receive news related to Vallon Pharmaceuticals, Inc.

Track Activities on VLON